Ligand Pharmaceuticals
LGND
LGND
308 hedge funds and large institutions have $3.63B invested in Ligand Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 99 increasing their positions, 100 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 270 → 308 (+38)
5.14% more ownership
Funds ownership: 99.47% → 104.62% (+5.1%)
1% less repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 100
Holders
308
Holding in Top 10
7
Calls
$3.51M
Puts
$2.04M
Top Buyers
| 1 | +$76.3M | |
| 2 | +$53.9M | |
| 3 | +$39.3M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$35.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$26.3M |
Top Sellers
| 1 | -$32M | |
| 2 | -$31M | |
| 3 | -$11.1M | |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
-$10.6M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$10.3M |
